Ascorbic acid Recruiting Phase 2 Trials for Myeloproliferative Neoplasms / Acute Myeloid Leukemia (AML) / Myelodysplastic Syndromes (MDS) Treatment

IndicationsStatusPurposePhase
RecruitingTreatment2
clinicaltrials.gov IdentifierTitleDrugs
NCT03397173TET2 Mutations in Myelodysplastic Syndromes and Acute Myeloid Leukemia With Azacitidine + Ascorbic Acid